As alphaviruses are sensitive to type I IFN restriction (26), we hypothesized that the blockade of IFN signaling with an anti-IFNAR1 monoclonal antibody (mAb), MAR1-5A3 (27), might increase the infection in the foot and DLN and accelerate the antigen-specific CD8+ T-cell response. Here, CD8A is linked to infection.